We didn’t wait for the next advance against cancer. We created it.
Learn why our CSO, Nick Keen, is #NotWaiting.
We didn’t wait for the next advance against cancer. We created it.
Learn why our U.K. team is #NotWaiting.
View all news

News

2 April 2019
Bicycle Therapeutics to Present at ELRIG’s Research & Innovation 2019 Conference

Social Media

@Bicycle_tx Apr 4
Bicycle employee Jo Longland ran the Cambridge Half Marathon, raising over £200 for Cancer Research UK. Congrats, J… http://FWEFvhH8vL

Our Programs

We are focused on developing three categories of Bicycles against our oncology targets:

Bicycle Toxin ConjugatesBicycle Targeted Innate Immune ActivatorsBicycle T-Cell Modulators

Our Technology

Learn about our revolutionary Bicycle technology

Beyond Oncology

Bicycle programs outside of cancer